Dynamic increase of serum HBsAg levels apportioned by the same hepatic parenchyma cell volume in HBe

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:maomaoniaoniao
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background:To discuss the dynamic changes of serum hepatitis B surface antigen(HBsAg) levels,and the serum HBsAg levels apportioned by the same hepatic parenchyma cell volume(HPCV),namely hepatic cell quantities,at different liver inflammation grades and hepatic fibrosis stages in HBeAg-positive chronic hepatitis B(CHB).Methods:152 HBeAg-positive CHB patients were recruited.The serum HBsAg levels were detected by electrochemiluminescence and the serum HBsAg apportioned by the same HPCV were figured out according to the theory of sphere geometry.The HBsAg levels were compared among different liver inflammation grades,as well as hepatic fibrosis stages,respectively.
其他文献
Background:Host genetic factor is one of important reasons for different response of antiviral treatment in chronic hepatitis B.IL-12 play an important role in immune to HBV.IL12A rs568408 is associat
会议
Background:Therapeutic strategy to activate host innate immunity,like toll-like receptor 7(TLR7) agonist,had a great potential for the treatment of chronic hepatitis B(CHB).Here we investigated the mo
会议
Background:Objectives:Fuzheng Huayu(FZHY) capsule,a Chinese medicine,is widely administrated to treat hepatic fibrosis and cirrhosis in the clinic in China for twenty years.This abstract is about to s
会议
Background:The zinc finger protein A20(also known as TNFAIP3) is a cytoplasmic protein and mediates the regulation of ubiquitin-dependent signaling in inflammation and immunity.Complex immune networks
会议
Background:Incidence of NAFLD(nonalcoholic fatty liver disease) is increasing as a cause of chronic liver disease.Also,obesity and diabetes are risk factors for the development of hepatocellular carci
会议
Background:It is of great importance to early and accurately predict the prognosis of patients with acute-onchronic hepatitis B liver failure(ACHBLF) for optimum management.The promoter methylation of
会议
Background:Hepatitis B virus core-related antigens(HBcrAg) are comprised of hepatitis B core antigen(HBcAg),hepatitis E antigen(HBeAg) and a 22 kDa precore protein(P22cr).HBcrAg concentrations were we
会议
Background:To compare the efficacy and safety of 52-week sequential therapy with telbivudine and other nucleoside analogs(NAs) in HBeAg-positive Chronic Hepatitis B Patients(CHB) patients with subopti
会议
Background:To characterize roles of serum hepatitis B virus markers(HBVM) quantitations in the prediction of natural phases of HBV infection.Methods:149 patients of chronic hepatitis B(CHB) undergone
会议
Background:Hepatitis B surface antigen clearance induced by interferon-α is associated with favorable clinical outcome.In this study,we investigated HBsAg kinetics during pegIFNα treatment and durabil
会议